{"product_id":"bukwang-business-model-canvas","title":"Bukwang Pharmaceutical Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBukwang Pharmaceutical: Business Model Unveiled!\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the strategic blueprint of Bukwang Pharmaceutical's thriving business model. This comprehensive Business Model Canvas details their customer segments, value propositions, and key revenue streams, offering a clear view of their market dominance. It's an essential tool for anyone looking to understand how they innovate and scale effectively. Want to delve deeper into the specifics of their operations and growth strategies?\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch Institutions \u0026amp; Universities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBukwang Pharmaceutical actively partners with research institutions and universities for the critical early stages of drug discovery. These collaborations focus on identifying novel drug candidates and conducting foundational preclinical studies, leveraging the academic world's deep scientific expertise. For instance, in 2024, Bukwang continued its engagement with leading Korean universities, sharing research data and jointly exploring innovative approaches to treating neurodegenerative diseases.\u003c\/p\u003e\n\u003cp\u003eThese academic alliances are vital for Bukwang's pipeline development, especially in challenging fields such as central nervous system (CNS) disorders. By tapping into specialized knowledge and state-of-the-art research facilities offered by universities, Bukwang can accelerate the validation of new therapeutic targets. This access to cutting-edge science is fundamental to bringing potentially life-changing treatments to market more efficiently.\u003c\/p\u003e\n\u003cp\u003eThe partnerships also extend to the rigorous process of clinical trials, where academic medical centers play a pivotal role. Bukwang's 2024 clinical trial initiatives, particularly for its novel treatments for Alzheimer's disease, relied heavily on the expertise and patient populations available through university hospitals. This collaborative approach ensures that drug development adheres to the highest scientific and ethical standards, increasing the likelihood of successful outcomes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Research Organizations (CROs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBukwang Pharmaceutical strategically partners with Contract Research Organizations (CROs) to accelerate its drug development pipeline. These alliances are crucial for managing the complex and data-intensive phases of clinical trials, ensuring compliance with global regulatory standards.  For instance, in 2024, the global CRO market was valued at approximately $50 billion, highlighting the significant role these specialized firms play in the pharmaceutical industry's R\u0026amp;D efforts.\u003c\/p\u003e\n\u003cp\u003eBy outsourcing specific research and development activities to CROs, Bukwang gains access to specialized expertise, advanced technologies, and a wider geographical reach for patient recruitment and trial execution. This collaborative approach allows Bukwang to optimize its resource allocation, reduce operational overhead, and ultimately expedite the time-to-market for its innovative therapies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributors and Wholesalers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBukwang Pharmaceutical heavily relies on its distributors and wholesalers to ensure its diverse product portfolio, including prescription drugs, over-the-counter (OTC) medications, and health supplements, reaches a wide audience. These partnerships are fundamental for effective market penetration and sales growth.\u003c\/p\u003e\n\u003cp\u003eThese crucial partners manage Bukwang's supply chain, ensuring timely delivery to pharmacies, hospitals, and other healthcare facilities across various regions. Their established networks are essential for Bukwang to maintain consistent product availability and expand its market reach. For instance, in 2024, the pharmaceutical distribution market in South Korea alone was projected to be a significant contributor to the overall healthcare sector's revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLicensing and Co-development Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBukwang Pharmaceutical strategically leverages licensing and co-development partnerships to enhance its product offerings and research capabilities.  The company actively seeks to license in promising drug candidates from other entities, thereby broadening its pipeline.  Simultaneously, Bukwang out-licenses its own developed technologies, generating revenue and expanding the reach of its innovations.  These collaborations are crucial for risk mitigation in research and development and for streamlining market entry for specialized therapies.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eLicensing In:\u003c\/strong\u003e Bukwang actively acquires rights to external drug candidates to enrich its development pipeline.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLicensing Out:\u003c\/strong\u003e The company out-licenses its proprietary technologies, creating additional revenue streams and market access.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCo-development:\u003c\/strong\u003e Bukwang collaborates with partners on joint research and development projects to share risks and accelerate progress.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePortfolio Expansion:\u003c\/strong\u003e These strategic partnerships enable Bukwang to broaden its therapeutic areas and strengthen its market position, particularly for niche treatments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Providers \u0026amp; Hospitals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBukwang Pharmaceutical’s key partnerships with healthcare providers and hospitals are foundational to its success, particularly for its specialty drugs targeting CNS, liver, and diabetes conditions. These relationships ensure that Bukwang’s innovative treatments reach the patients who need them.  The company focuses on direct engagement with physicians, presenting robust clinical data to support the efficacy and safety of its products.\u003c\/p\u003e\n\u003cp\u003eEnsuring product availability is another crucial aspect of these partnerships. This involves working closely with hospital pharmacies to streamline the supply chain and guarantee that medications are readily accessible. For example, the successful integration of Latuda into major Korean hospitals highlights Bukwang’s ability to establish and maintain these vital distribution channels.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eHospital Integration:\u003c\/strong\u003e Bukwang actively works to get its specialty drugs, like those for CNS and liver diseases, included in hospital formularies and treatment protocols.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical Data Dissemination:\u003c\/strong\u003e Partnerships involve sharing comprehensive clinical trial results and real-world evidence with hospital-based medical professionals to drive prescription volume.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupply Chain Reliability:\u003c\/strong\u003e Collaborations ensure a consistent and reliable supply of Bukwang’s pharmaceuticals to hospital pharmacies, preventing stockouts and supporting patient care continuity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket Penetration:\u003c\/strong\u003e The success of drugs like Latuda in major Korean hospitals demonstrates the effectiveness of Bukwang’s strategy in securing significant market share through provider partnerships.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccelerating Drug Development with Key Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBukwang Pharmaceutical's key partnerships with Contract Research Organizations (CROs) are essential for accelerating drug development, particularly in navigating complex clinical trials and adhering to global regulatory standards. In 2024, the global CRO market was valued at approximately $50 billion, underscoring the significant role these specialized firms play in the pharmaceutical R\u0026amp;D landscape by providing expertise, technology, and patient access.\u003c\/p\u003e\n\u003cp\u003eThese collaborations enable Bukwang to optimize resource allocation, reduce operational costs, and expedite the time-to-market for its innovative therapies, as demonstrated by their continued reliance on CRO services for ongoing clinical programs in 2024.\u003c\/p\u003e\n\u003cp\u003eThe company also strategically engages with academic institutions and universities for early-stage drug discovery and preclinical research, leveraging their scientific expertise to identify novel therapeutic targets and candidates. These alliances are critical for pipeline development, especially in challenging areas like CNS disorders.\u003c\/p\u003e\n\u003cp\u003eBukwang further strengthens its product portfolio through licensing and co-development agreements, acquiring promising drug candidates and out-licensing its own technologies to share risks, generate revenue, and expand market reach for specialized treatments.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartnership Type\u003c\/td\u003e\n\u003ctd\u003eStrategic Importance\u003c\/td\u003e\n\u003ctd\u003e2024 Focus\/Example\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eContract Research Organizations (CROs)\u003c\/td\u003e\n\u003ctd\u003eAccelerating clinical trials, regulatory compliance\u003c\/td\u003e\n\u003ctd\u003eGlobal CRO market valued at ~$50 billion; crucial for trial execution and data management.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademic Institutions\/Universities\u003c\/td\u003e\n\u003ctd\u003eEarly-stage drug discovery, preclinical research\u003c\/td\u003e\n\u003ctd\u003eJoint research on neurodegenerative diseases with Korean universities; identifying novel CNS targets.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLicensing \u0026amp; Co-development\u003c\/td\u003e\n\u003ctd\u003ePipeline enrichment, risk sharing, revenue generation\u003c\/td\u003e\n\u003ctd\u003eAcquiring external drug candidates and out-licensing proprietary technologies.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eBukwang Pharmaceutical's Business Model Canvas outlines a strategy focused on developing innovative treatments for unmet medical needs, leveraging strategic partnerships and a robust R\u0026amp;D pipeline.\u003c\/p\u003e\n\u003cp\u003eIt details how the company will deliver value to patients and healthcare providers through specialized drug development, supported by efficient manufacturing and global distribution channels.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eBukwang Pharmaceutical's Business Model Canvas acts as a pain point reliever by providing a clear, visual map of their operations, enabling faster identification of inefficiencies and opportunities for improvement.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development (R\u0026amp;D)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBukwang Pharmaceutical's core strength lies in its robust Research and Development (R\u0026amp;D) activities.  The company dedicates significant resources to discovering and developing new drug candidates, particularly targeting challenging areas like central nervous system (CNS) disorders, liver diseases, and diabetes.  This commitment extends from early-stage preclinical research and lead optimization through to the rigorous stages of clinical trials for both new chemical entities and enhanced drug formulations.\u003c\/p\u003e\n\u003cp\u003eA key strategic initiative for Bukwang is the expansion of its research capabilities, with a notable focus on establishing an advanced platform for developing RNA-based small molecule therapeutics.  This forward-looking approach aims to tap into cutting-edge biotechnologies to broaden its pipeline and address unmet medical needs.  In 2024, Bukwang continued to invest heavily in R\u0026amp;D, with a significant portion of its operational budget allocated to these crucial activities, underscoring its long-term vision for innovation in the pharmaceutical sector.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBukwang Pharmaceutical's core activity revolves around the manufacturing of a broad spectrum of pharmaceutical goods. This encompasses everything from vital prescription medications to widely accessible over-the-counter drugs and nutritional health supplements, catering to diverse healthcare needs.\u003c\/p\u003e\n\u003cp\u003eThis manufacturing process is meticulously designed to uphold stringent quality control, ensuring all products meet rigorous regulatory standards. Maintaining a consistent and reliable supply chain is paramount to effectively meet fluctuating market demands and patient requirements.\u003c\/p\u003e\n\u003cp\u003eLooking ahead, Bukwang Pharmaceutical is strategically planning substantial capital investments aimed at significantly expanding its existing manufacturing capabilities. This expansion is crucial for scaling production to accommodate future growth and new product pipelines.\u003c\/p\u003e\n\u003cp\u003eFor instance, in late 2023, Bukwang announced a plan to invest approximately 20 billion KRW (around $15 million USD) in upgrading its production facilities, with a focus on enhancing its biologics manufacturing capacity, a key area for future growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Trials Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eManaging and executing clinical trials is a core activity for Bukwang Pharmaceutical, crucial for proving the safety and effectiveness of their new drug candidates.  This encompasses everything from finding suitable patients and gathering accurate data to preparing regulatory documents and analyzing results.  These steps are absolutely vital for obtaining market approval for innovative treatments, such as their Parkinson's disease drug candidate, CP-012.\u003c\/p\u003e\n\u003cp\u003eBukwang's commitment to this area is evident through its subsidiary, Contera Pharma, which actively manages and conducts these essential clinical trials.  By late 2023, Contera Pharma had successfully enrolled over 100 participants in Phase 2 trials for CP-012, demonstrating significant progress in the drug development pipeline and highlighting the company's operational capacity in trial execution.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketing and Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBukwang Pharmaceutical's marketing and sales efforts are vital for its success, focusing on promoting its diverse product range. These strategies target healthcare professionals, pharmacies, and ultimately, consumers, ensuring broad product adoption and market penetration.\u003c\/p\u003e\n\u003cp\u003eKey activities include deploying a robust medical representative force to engage directly with doctors and pharmacists. Bukwang also actively participates in major medical conferences and symposia, providing platforms to showcase clinical data and build relationships within the medical community. Targeted promotional campaigns are designed to highlight the benefits of their flagship products, such as Latuda and Dexid, aiming to capture significant market share.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedical Representative Engagement:\u003c\/strong\u003e Direct outreach to healthcare providers to educate them on Bukwang's pharmaceuticals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConference Participation:\u003c\/strong\u003e Presence at industry events to share research and foster professional connections.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTargeted Marketing Campaigns:\u003c\/strong\u003e Specific promotions for key drugs like Latuda and Dexid to boost sales and awareness.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigital Marketing Initiatives:\u003c\/strong\u003e Leveraging online channels to reach a wider audience and provide product information.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Affairs and Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBukwang Pharmaceutical's key activities heavily involve navigating the complex landscape of regulatory affairs and compliance. This is crucial for ensuring their products meet stringent quality and safety standards.  For example, in 2024, the company would be actively managing product registrations and re-registrations across various markets, a process that can take years and significant resources.\u003c\/p\u003e\n\u003cp\u003eMaintaining strict adherence to regulations like Good Manufacturing Practices (GMP) is a daily operational necessity. This includes rigorous documentation and quality control at every stage, from research and development to post-market surveillance. Failure to comply can lead to significant penalties and product recalls, impacting both patient safety and the company's reputation.\u003c\/p\u003e\n\u003cp\u003eKey activities include:\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eDossier Preparation and Submission:\u003c\/strong\u003e Compiling and submitting comprehensive documentation to health authorities for new drug approvals and variations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduct Registration Management:\u003c\/strong\u003e Overseeing the entire lifecycle of product registrations, including initial approvals, renewals, and post-approval changes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality Assurance and Control:\u003c\/strong\u003e Implementing and maintaining robust quality management systems to ensure product integrity and compliance with pharmacopoeial standards.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdherence to Pharmacovigilance:\u003c\/strong\u003e Establishing systems for monitoring and reporting adverse drug reactions to ensure ongoing patient safety.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Innovation: R\u0026amp;D, Clinical Trials, and Market Focus\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBukwang Pharmaceutical's key activities center on its core competencies in research and development, manufacturing, clinical trial management, and marketing. The company focuses on developing innovative treatments, particularly for CNS disorders and liver diseases, and on ensuring the quality and accessibility of its diverse product portfolio, which includes prescription drugs, OTC products, and supplements.\u003c\/p\u003e\n\u003cp\u003eThe company actively manages clinical trials, with its subsidiary Contera Pharma playing a crucial role in advancing drug candidates like CP-012 for Parkinson's disease, demonstrating progress through patient enrollment. Bukwang also engages in robust marketing and sales strategies, utilizing a medical representative force and digital initiatives to promote its products, such as Latuda and Dexid, to healthcare professionals and consumers.\u003c\/p\u003e\n\u003cp\u003eFurthermore, navigating regulatory affairs and maintaining compliance with standards like GMP are essential daily activities. This ensures product safety and market approval, involving meticulous dossier preparation, registration management, and pharmacovigilance systems. In 2024, Bukwang continued its investment in R\u0026amp;D and manufacturing upgrades, including a 20 billion KRW investment in biologics capacity.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Bukwang Pharmaceutical Business Model Canvas preview you are viewing is the actual document you will receive upon purchase. This means you are seeing the complete, unedited content and structure that will be delivered to you. You can trust that the detailed breakdown of Bukwang's strategy, from key partners to revenue streams, is exactly what you will get, allowing you to directly analyze and utilize this comprehensive business overview.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55480499110265,"sku":"bukwang-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/bukwang-business-model-canvas.png?v=1752754601","url":"https:\/\/growthsharematrix.com\/products\/bukwang-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}